Under construction – not a live service

Skip to content

Frontlight Research

Trial site

MEDI-K (Site 0807)

Guatemala City, GuatemalaNot linked to an institution yet

0running trials
1closed trial
0trials confirmed by the site in the last 60 days
–languages not stated

No trial has been confirmed here yet.

Running trials

No running trial is registered here.

Researchers

No researcher is linked here yet.

Closed trials

Completed
Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006)
NCT05298423· Phase 3· Source

Site data: ClinicalTrials.govUpdated 5 Nov 2026

Report an error

Under construction, not live – MEDI-K (Site 0807): trial site – Frontlight Research